Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov 20;16(1):431.
doi: 10.1186/s13256-022-03652-9.

Fluoxetine for the treatment of onychotillomania associated with obsessive-compulsive disorder: a case report

Affiliations
Case Reports

Fluoxetine for the treatment of onychotillomania associated with obsessive-compulsive disorder: a case report

Sumayah Aljhani. J Med Case Rep. .

Abstract

Background: Obsessive-compulsive disorder is a condition in which patients experience an obsession and/or a compulsion. It has a high impact on the quality of life, and is associated with an increased prevalence of psychiatric comorbidities in patients. Onychotillomania is an underestimated psychodermatosis caused by repeated self-inflicted damage to the nail unit. In patients, it is characterized by an obsessive or irrepressible impulse to repeatedly damage their own nails, resulting in their destruction. It is a chronic condition that is difficult to manage, largely because of its psychocutaneous character, as well as its high tendency to interact with underlying neuropsychiatric diseases or other behavioral disorders. Only a few studies have reported an association between obsessive-compulsive disorder and onychotillomania, which typically presents with therapeutic challenges. Cognitive behavioral therapy, physical-barrier approaches, and pharmaceutical treatments have been reported to be beneficial in the management of onychotillomania; however, no major clinical studies have investigated the effectiveness of these therapies. Onychotillomania remains a clinical and therapeutic issue owing to the lack of evidence-based treatment techniques.

Case presentation: We report a case of an 18-year-old, middle-eastern female patient who developed onychotillomania when she was being treated with paroxetine for obsessive-compulsive disorder and was showing partial improvement. The patient developed side effects from paroxetine, and was switched to fluoxetine. Thereafter, improvement in her obsessive-compulsive disorder was observed, which relapsed when treatment was discontinued. However, the onychotillomania symptoms did not reemerge.

Conclusion: Onychotillomania typically presents both diagnostic and therapeutic challenges. Fluoxetine plays an important role in the treatment of onychotillomania and other psychiatric disorders. However, large-scale studies should be conducted before these outcomes can be generalized.

Keywords: Fluoxetine; Focused body repetitive behavior; Nail tic disorders; Obsessive–compulsive disorder; Onychotillomania; Paroxetine.

PubMed Disclaimer

Conflict of interest statement

The author has no conflict of interest to declare.

Figures

Fig. 1
Fig. 1
Lateral erythematous, swollen, and bleeding nail folds of the big toes
Fig. 2
Fig. 2
Distolateral swelling and bleeding indicating ingrowing of the left big toenail

Similar articles

References

    1. Asken MJ, Grossman D, Christensen LW, American Psychiatric Association . Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Publishing; 2013.
    1. Dell’Osso B, Benatti B, Arici C, Palazzo C, et al. Prevalence of suicide attempt and clinical characteristics of suicide attempters with obsessive–compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) CNS Spectr. 2018;23:59–66. doi: 10.1017/S1092852917000177. - DOI - PubMed
    1. Bayes A, Parker G. Onychotillomania and secondary foot cellulitis. Aust N Z J Psychiatry. 2017;51:1158–1159. doi: 10.1177/0004867417710732. - DOI - PubMed
    1. Nazeer A, Latif F, Mondal A, Azeem MW, Greydanus DE. Obsessive–compulsive disorder in children and adolescents: epidemiology, diagnosis and management. Transl Pediatr. 2020;9(Suppl 1):S76–S93. doi: 10.21037/tp.2019.10.02. - DOI - PMC - PubMed
    1. NIMH. Obsessive–compulsive disorder; 2019. https://www.nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd. Accessed Feb 2022

Publication types